ng-nitroarginine methyl ester has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ancrile, BB; Barrientos, KS; Cardona, DM; Counter, CM; Crowe, MS; Gurley, SB; Kashatus, DF; Kendall, SD; Lampson, BL; Morrison, MM; Shealy, MJ; White, RR | 1 |
Adrian, TE; Knezetic, JA; Thomas, DL; Thomas, WJ | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Targeting eNOS in pancreatic cancer.
Topics: Animals; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Pancreatic Neoplasms; ras Proteins; Stromal Cells; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Division; Cytokines; Enzyme Inhibitors; Free Radical Scavengers; Humans; Interferon-gamma; Interleukin-1; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Pancreatic Neoplasms; Protein Kinase C; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |